--- title: Validating a Multiplex STI Panel With Non-Invasive Sample Types description: Multiplex PCR testing has become important in sexually transmitted infection (STI) testing. This webinar covers how to approach four commonly requested STI tests. image: https://info.darkdaily.com/hubfs/Multiplex-Panel-PCR-Testing-AdobeStock_176623738-sq.jpeg --- [![dark daily logo-no tags-FIT](https://info.darkdaily.com/hubfs/dark%20daily%20logo-no%20tags-FIT.png)](https://www.darkdaily.com/) ## FREE WEBINAR # Validating a Multiplex STI Panel With Non-Invasive Sample Types #### Unleash the Potential #### Aired September 27, 2023 [![STREAM ON DEMAND](https://no-cache.hubspot.com/cta/default/19537694/cf4a4c2e-8c2f-4aac-8e8c-f9c966995b93.png)](https://cta-redirect.hubspot.com/cta/redirect/19537694/cf4a4c2e-8c2f-4aac-8e8c-f9c966995b93) ###### Free Webinar with Live Q&A ## Validating a Multiplex STI Panel With Non-Invasive Sample Types Unleash the Potential ###### Why Attend Sexually transmitted infections (STIs) represent a unique healthcare burden in the United States with over 20 million new cases every year and an urgent need to control the spread. A multiplex PCR approach to STI testing has emerged as an economical and broader approach to routine STI and urgent STI testing. However, a practical challenge of implementing an STI multiplex panel is validation. Learn from *DarkDaily's* complimentary webinar, **"Validating a Multiplex STI Panel With Non-Invasive Sample Types: Unleash the Potential."** This free webinar with live Q&A focuses on adapting to and validating a single assay for four commonly requested STI tests: *Chlamydia trachomatis* (CT), *Neisseria gonorrhea* (NG), *Mycoplasma genitalium* (MG), and *Trichomonas vaginalis* (TV), using two separate PCR platforms and non-invasive sample types. #### [![STREAM ON DEMAND](https://no-cache.hubspot.com/cta/default/19537694/cf4a4c2e-8c2f-4aac-8e8c-f9c966995b93.png)](https://cta-redirect.hubspot.com/cta/redirect/19537694/cf4a4c2e-8c2f-4aac-8e8c-f9c966995b93) #### Key Learnings - Overview of the disease burden of sexually transmitted infections (STIs) - Lessons from adapting lab operations to test for multiple targets using PCR platforms - Key concepts for validating a multiplex STI panel as a laboratory developed test - Understand the use of urine as a viable non-invasive sample type for STI testing #### Who Should Attend • Lab directors, technical supervisors, and medical/microbiology laboratory supervisors  • Coordinators and supervisors of point of care testing • Quality system and quality assurance managers ### About the Expert ![Vijay-Singh-PCR-Testing-sm](https://info.darkdaily.com/hubfs/Vijay-Singh-PCR-Testing-sm.jpg) **Vijay Singh, PhD** Vice President, Research and Development HealthTrackRx Vijay Singh, PhD, is Vice President of Research and Development at HealthTrackRx in Denton, Texas. Dr. Singh leads the development of molecular tests for pathogen and disease targets on qPCR and NGS platforms. Prior to this role, Dr. Singh achieved his PhD in molecular biology and post-doctoral training in metabolic engineering at the University of North Texas. #### [![STREAM ON DEMAND](https://no-cache.hubspot.com/cta/default/19537694/cf4a4c2e-8c2f-4aac-8e8c-f9c966995b93.png)](https://cta-redirect.hubspot.com/cta/redirect/19537694/cf4a4c2e-8c2f-4aac-8e8c-f9c966995b93) ##### Sponsored By ![Multiplex PCR Testing Testing Webinar](https://info.darkdaily.com/hubfs/purepng.com-thermo-fisher-scientific-logologobrand-logoiconslogos-251519940288wy078.png) ![dark daily logo-no tags-FIT-white](https://info.darkdaily.com/hubfs/dark%20daily%20logo-no%20tags-FIT-white.png) The Dark Intelligence Group 21806 Briarcliff Dr. Spicewood, TX 78669 Email: [info@darkreport.com](mailto:info@darkreport.com) Phone: 512-264-7103 Fax: 512-264-0969 - - [Home](https://www.darkdaily.com) - [Dark Report](https://www.darkintelligencegroup.com/) - [Lab Resources](https://www.darkdaily.com/laboratory-resources-2/) - [Special Reports](https://www.darkdaily.com/special-reports-library/) - [E-Briefings](https://www.darkdaily.com/ebriefings/) - - [Webinars](https://www.darkdaily.com/webinar/) - [White Papers](https://www.darkdaily.com/whitepapers/) - [Lead Generation](https://www.darkdaily.com/marketing-programs-and-opportunities-for-laboratory-and-pathology-companies/) - [Press Releases](https://www.darkdaily.com/press-releases/) © 2026 All rights reserved.